[This stock definitely has one of the biggest boom potentials in the entire market. The company has a drug with an orphan drug designation and it only has a $1.5 million market cap. It makes little sense. On that alone it should be trading 20x to 30x higher at a minimum. Then add in a potential Phase II trial and it should be even higher. Of course if they don't get the funding then all bets are off and it has bust potential as well. But the potential upside here is truly amazing. Hopefully he is able to secure friendly financing soon. ]
Yah but the CEO and the entire management team is "MIAs" missing in action for well over a year... if they had some good news they would have put it out there long time ago.... How can they put a rosy picture on N endless dilution and notes conversions.... It seams as though that IS they business model ,LOLzzz
Range is .0007 -.0008
Can any one spell M_A_N_I_P_U_L_A_T_I_O_N
Feb, 2018 maybe then
NPHC